Centers & Services
Top > Centers & Services > Central Clinical Services > Immune-Mediated Diseases Therapy Center
Immune-Mediated Diseases Therapy Center

Medical services
The first consultation is the Immune-Mediated Diseases Therapy Center outpatient clinic every Monday morning. This center provides medical care with physicians from departments that specialize in various immunological diseases (Allergy and Rheumatology, Hematology and Oncology, Gastroenterology, Neurology, Geriatric Medicine (Dementia center), Dermatology, Ophthalmology, Orthopaedic Surgery and Spinal Surgery, Colon and Rectal Surgery).
Diagnosis and treatment policy
The number of molecularly targeted drugs that have had a tremendous impact on immunological diseases is increasing every year, and the number of diseases that are subject to such drugs is also increasing. The center coordinates with the specialized departments for each disease, to provide safer and more effective drugs. Detailed studies are carried out at the regularly held “Meeting of Immunemediated disease therapy center”.
Specialties
Physicians specializing in molecularly targeted treatments select a safe and ef fective molecularly targeted drug, and support patients to continue the treatment at ease.
Target diseases
Rheumatoid ar thritis, Systemic lupus erythematosus, Systemic sclerosis, Ankylosing spondylitis, Behcet’s disease, Psoriasis & Psoriatic arthritis, Crohn’s disease, Ulcerative colitis, Multiple sclerosis, Neuromyelitis optica spectrum disorders, Non-infectious uvetis, Angitis, Adult onset still’s disease, Systemic sclerosis, Autoinflammatory disease (Cryopyrin-associated periodic syndrome, Familial mediterranean fever, TNF receptor-associated periodic syndrome, High IgD syndrome), Alzeheimer’s dementia etc.

Hiroko Kanda
Departments/Divisions
Immune-Mediated Diseases Therapy Center
Titles
M.D., Ph.D.
Expertise/Specialties
Immune-Mediated Diseases (mainly rheumatic disease and collagen diseases)
Research Interests
Elucidation of pathogenesis and development of treatment for rheumatoid arthritis and psoriatic arthritis
Investigating the safety of molecularly targeted therapy for Immune-Mediated Diseases Therapy for Immune-Related Diseases
Languages
Japanese
under construction